Global Computed Tomography Devices Market Size to grow at a CAGR of 6.15% to reach USD 13,460.21 million by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The growing burden of chronic diseases including cancer, cardiovascular conditions, and respiratory disorders is driving higher demand for diagnostic imaging, positioning computed tomography (CT) devices as vital tools for early detection and ongoing monitoring. Advancements such as faster scan times, improved image clarity, and reduced radiation exposure are enhancing efficiency and safety, further supporting their adoption in healthcare settings. Additionally, leading companies are introducing innovative solutions like portable and AI-enabled CT systems, which enhance diagnostic precision and broaden the use of CT technology across multiple medical specialties. Together, these factors are expected to fuel CT device market growth throughout the 2025-2032 forecast period.

DelveInsight's "Computed Tomography Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Computed Tomography Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Computed Tomography Devices market, get a snapshot of the report Computed Tomography Devices Market Trends
https://www.delveinsight.com/sample-request/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Computed Tomography Devices Overview
Computed Tomography (CT) devices are medical imaging machines that use X-rays and computer processing to create detailed cross-sectional images of the body. These images provide a 3D view of internal organs, bones, blood vessels, and tissues, helping in the diagnosis, monitoring, and treatment planning of various conditions, including cancers, cardiovascular diseases, trauma, and infections. CT devices are faster and more detailed than standard X-rays and are commonly used in hospitals, diagnostic centers, and emergency care for precise, non-invasive imaging.

DelveInsight Analysis: The computed tomography devices market size was valued at USD 8,400.69 million in 2024, is expected to grow at a CAGR of 6.15% from 2025 to 2032, reaching USD 13,460.21 million by 2032.

Computed Tomography Devices Market Insights
Geographically, North America is anticipated to lead the global computed tomography (CT) devices market in 2024, supported by the growing prevalence of cancer, respiratory conditions, and cardiovascular diseases. Ongoing technological innovations and a steady rise in product approvals and launches further strengthen the region's dominant position.

To read more about the latest highlights related to Computed Tomography Devices, get a snapshot of the key highlights entailed in the Computed Tomography Devices Insights
https://www.delveinsight.com/report-store/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Computed Tomography Devices Market Report
• In Sept 2025, 4DMedical received FDA 510(k) clearance for CT:VQTM, the first non-contrast ventilation-perfusion (VQ) imaging solution. CMS confirmed reimbursement under Category III CPT codes, supplementing chest CT payments. CT:VQ software converts standard chest CTs into detailed lung ventilation and perfusion maps, integrating seamlessly into radiology workflows and expanding functional lung imaging access without nuclear medicine.
• In August 2025, DeepHealth, Inc., a RadNet subsidiary, received FDA 510(k) clearance for TechLiveTM - a remote scanning solution for centralized control of MR, CT, PET/CT, and Ultrasound procedures. TechLiveTM helps address tech labor shortages by allowing technologists to operate scans across multiple locations, improving efficiency, extending hours, and boosting patient access. Over 300 RadNet imaging systems now use TechLiveTM, increasing patient throughput and enhancing quality with real-time expert support.
• In May 2025, GE HealthCare (Nasdaq: GEHC) launched CleaRecon DL, an AI-powered deep-learning technology that enhances cone-beam CT (CBCT) image quality. Designed for use in liver, prostate, neuro, and endovascular aortic repair procedures, it reduces streak artifacts from blood flow and contrast changes. CleaRecon DL has received U.S. FDA 510(k) clearance and CE mark, and will be available on the AlliaTM platform.
• In May 2025, GE HealthCare announced that the FDA granted 510(k) clearance for its Aurora nuclear medicine system and Clarify DL. This advanced dual-head SPECT/CT system is designed to enhance diagnostic capabilities and improve workflow efficiency, providing clinicians with superior image quality and streamlined operations.
• In April 2025, Brainomix announced FDA clearance of a novel feature in its Brainomix 360 Stroke solution that allows physicians to assess ischemic core volume using standard non-contrast CT (NCCT) images. This feature, validated by leading US stroke centers, shows accuracy comparable to CT Perfusion and MRI assessments.
• In March 2025, the FDA granted 510(k) clearance for Johnson & Johnson (J&J) MedTech's Monarch Quest for robotic-assisted bronchoscopy procedures. This solution features AI-powered algorithms and a verified OEC Open interface with GE HealthCare's OEC 3D mobile cone-beam CT imaging system, marking a new advancement in Monarch navigation technology.
• In March 2025, Fovia Ai, Inc., a leader in AI analysis and workflow software, received FDA 510(k) clearance for F.A.S.T.® aiCockpit® CT Lung Nodule through its parent company, Fovia, Inc. This application helps radiologists efficiently visualize, navigate, edit, and accept or reject lung nodule detection algorithm results.
• In July 2024, Trivitron Healthcare announced the launch of its advanced CT scanner, ""Terrene,"" which became the first in India to receive approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB), and the Central Drugs Standard Control Organization (CDSCO), marking a significant milestone in the country's healthcare industry.
• In April 2022, Wipro GE Healthcare announced the launch of its next-generation Revolution Aspire CT scanner, designed and manufactured entirely in India at the Wipro GE Medical Devices Manufacturing plant. This advanced imaging solution, aligned with the 'Atmanirbhar Bharat' initiative, features enhanced imaging intelligence to improve clinical confidence in diagnosing diseases and anomalies.
• Thus, owing to such developments in the market, rapid growth will be observed in the Computed Tomography Devices market during the forecast period

Key Players in the Computed Tomography Devices Market
Some of the key market players operating in the Computed Tomography Devices market include- General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd., MR Solutions, and others.

Which MedTech key players in the Computed Tomography Devices market are set to emerge as the trendsetter explore @ Key Computed Tomography Devices Companies
https://www.delveinsight.com/sample-request/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Computed Tomography Devices Market Landscape
Increasing strategic initiatives by leading market players are accelerating the adoption of portable CT technologies. For instance, in October 2022, NeuroLogica Corp., a Samsung Electronics subsidiary, announced that its Elite Mobile CT systems received CE marking under the EU Medical Device Regulation (MDR 2017/745). This certification, issued by the EU's Notified Body, confirmed compliance for the OmniTom Elite, BodyTom Elite, and CereTom Elite mobile CT systems, strengthening their regulatory standing and expanding their market reach.
As demand for point-of-care imaging continues to rise, the portable CT scanner segment is poised for substantial growth, contributing notably to the expansion of the global CT devices market over the forecast period.

Scope of the Computed Tomography Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Computed Tomography Devices Market Segmentation By Type: Stationary CT Scanners and Portable CT Scanners
• Computed Tomography Devices Market Segmentation By Modality: O-Arm and C-Arm
• Computed Tomography Devices Market Segmentation By Technology: Low End, Mid-End, and High End)
• Computed Tomography Devices Market Segmentation By Application: Oncology, Cardiology, Neurology, and Others
• Computed Tomography Devices Market Segmentation By End-User: Hospitals, Diagnostic Imaging Centers, and Others
• Computed Tomography Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Computed Tomography Devices Companies: General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, NeuroLogica Corp. (Samsung Electronics), Shimadzu Corp., Thermo Fisher Scientific, Xoran Technologies LLC, Trivitron Healthcare, Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., PerkinElmer Inc., ICRco, Inc., MARS Bioimaging Ltd., United Imaging Healthcare Co., Ltd., SternMed GmbH, MinFound Medical Systems Co., Ltd., MR Solutions, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Computed Tomography Devices market will grow by 2032? Click to get a snapshot of the Computed Tomography Devices Market Analysis
https://www.delveinsight.com/sample-request/computed-tomography-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.